Jul 2026· International Heart Journal· Vol 67 4, pp.
333-341
· 0 citations· 20 references
Medicine
TL;DR
LA phasic dysfunction was most evident in young adult CCSs despite preserved conventional diastolic indices, suggesting that age-stratified LA strain assessment may help identify survivorship stages at which atrial dysfunction becomes detectable.
Abstract
Childhood cancer survivors (CCSs) are at increased risk of cancer therapy-related cardiac dysfunction following anthracycline chemotherapy. Although left atrial (LA) strain assessed by speckle-tracking echocardiography has emerged as a sensitive marker of diastolic dysfunction, it remains unclear when during survivorship LA dysfunction becomes detectable in CCSs treated with anthracyclines.In this retrospective observational case-control study, 92 CCSs (aged 4-32 years) and 96 age-matched healthy controls underwent echocardiography. Participants were stratified into three age groups (4-12, 13-18, and 19-32 years). LA reservoir, conduit, and pump strains were measured using two-dimensional speckle-tracking echocardiography from the apical four-chamber view. Conventional echocardiographic parameters, including mitral inflow velocities (E and A waves), E/A ratio, and tissue Doppler-derived e' and E/e', as well as left ventricular longitudinal strain (LVLS), were assessed.Conventional diastolic parameters did not significantly differ between CCSs and controls within corresponding age groups. However, in young adult CCSs (19-32 years), all three components of LA phasic strain (reservoir, conduit, and pump strains) were significantly reduced compared with age-matched controls. LVLS was also significantly lower in this group, whereas younger CCSs showed no significant differences in LA strain.LA phasic dysfunction was most evident in young adult CCSs despite preserved conventional diastolic indices, suggesting that age-stratified LA strain assessment may help identify survivorship stages at which atrial dysfunction becomes detectable.
Survival after acute lymphoblastic leukaemia (ALL) now exceeds 90% following intensive chemotherapy. Anthracyclines remain integral to treatment but are associated with chemotherapy-related cardiac dysfunction (CTRCD), ranging from subclinical myocardial impairment to overt heart failure. Conventional surveillanc...
P. H. Johnsen, C. A. Frederiksen, S. Poulsen et al.· European Heart Journal, Supp...· 0 citations
Improved childhood cancer survival has been accompanied by substantial late morbidity and mortality related to cardiotoxic cancer therapies. We conducted a retrospective study of childhood cancer survivors (CCS) diagnosed before age 21 and followed at The Children's Hospital at Montefiore (CHAM). Collected data include...
J. Wilcox, Leya Schwartz, J. Mahgerefteh et al.· Pediatric Cardiology· 0 citations
Alterations in left atrial strain (LAS) may reflect early functional changes not captured by conventional cancer-therapy-related cardiac dysfunction indices. However, how LAS evolves during chemotherapy and whether its trajectory differs according to baseline cardiovascular risk remain unclear.
To evaluate...
B. Zholdin, A. Amanova, S. Balmagambetova et al.· European Heart Journal, Supp...· 0 citations
A dose-dependent effect on subclinical cardiac function is suggested in childhood cancer survivors treated with anthracyclines, and incorporating CMR-FT strain assessment into the cardiac monitoring of CCS may help identify subclinical CTRCD in this population.
M. Mojica-Pisciotti, Roman Panovský, T. Holeček et al.· Clinical Research in Cardiol...· 0 citations
In this cohort of women treated with anthracyclines and anti-HER2 therapy, RV-FWLS identified patients who developed CTRCD, supporting RV strain as a useful tool for early risk stratification and refinement of cardio-oncology surveillance strategies.
B. Andrade, N. Cotrim, C. Coelho et al.· European Heart Journal, Supp...· 0 citations
It is suggested that RV strain assessment provides information complementary to conventional LV–based cardiotoxicity criteria and may occur in the absence of concurrent changes in conventional LV cardiotoxicity parameters as currently defined.
Z. Tlegenova, A. Amanova, S. Balmagambetova et al.· European Heart Journal, Supp...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.